According to FutureWise analysis, the market for bovine mastitis in 2023 is US$1.48 billion, and is expected to reach US$2.26 billion by 2031 at a CAGR of 5.4%.

The global Bovine Mastitis Market was valued at approximately USD 3.6 billion in 2024 and is anticipated to surge to around USD 5.9 billion by 2034. This growth trajectory reflects a robust compound annual growth rate (CAGR) of about 5.0% during the forecast period spanning from 2025 to 2034. Key factors driving this expansion include the rising incidence of bovine mastitis among dairy cattle, which has heightened concerns for animal welfare and productivity within the dairy industry. Moreover, there is an increasing global awareness regarding the importance of animal health, alongside a burgeoning demand for milk and dairy products, both of which are contributing to the market's upward momentum. Innovations in diagnostic technologies are playing a pivotal role, enabling early detection and more effective management of the disease. Improved veterinary care practices and the growing adoption of intramammary antibiotic treatments, as well as vaccines designed specifically for mastitis prevention, are also significant contributors to market growth. Geographically, North America currently leads the market, attributed to its well-established and advanced dairy infrastructure that supports efficient dairy farming practices. In contrast, the Asia-Pacific region is poised for the most rapid growth, driven by a surge in dairy farming activities and heightened investments in livestock health initiatives, reflecting a promising shift in the market dynamics on a global scale.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Bovine Mastitis Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=10191&type=requestsample

Bovine Mastitis Market Segmentation:

By Type

• Clinical Mastitis
• Sub-clinical Mastitis

By Product

• Antibiotics
• Others

By Route of Administration

• Intramammary
• Systemic

By Therapy

• Lactating Period
• Dry Period
• Antibiotics
• Teat sealants

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Bovine Mastitis Market:

• Zoetis 
• MerckCo., Inc. (MSD Animal Health) 
• Boehringer Ingelheim International GmbH 
• Bayer AG
• Elanco
• Ceva
• West Way Health 

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=10191&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Bovine Mastitis Market By Type, By Product, By Route of Administration, By Therapy and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com